Active Pharmaceutical Ingredients – API – Active Pharmaceutical Ingredients #pharma #packaging

Posted On Dec 19 2017 by

#api pharma # Active Pharmaceutical Ingredients – API Also known as API. Active Pharmaceutical Ingredients are portions of any drug, which are active. Thus, depending on the drug’s administered dosage, the reactions and results differ. Certain drugs are comprised of more than one kind of API . Components of a drug Any drug is composed of two components or aspects. The first is the actual API or Active Pharmaceutical Ingredients. which is the central ingredient. The second is known as an excipient. This refers to the substance inside the drug or tablet. If it is in syrup form, then the …


Humanwell Healthcare Group and PuraCap Pharmaceutical LLC to Acquire Epic Pharma, LLC #major #pharmaceutical #companies

Posted On Dec 19 2017 by

#epic pharma # Humanwell Healthcare Group and PuraCap Pharmaceutical LLC to Acquire Epic Pharma, LLC The acquisition of Epic will provide a robust generic product portfolio which includes tablets, 2-piece capsules and powder dosage form products as well as a future product portfolio that will include a series of controlled drug substances. Humanwell and PuraCap will acquire Epic’s balanced and diversified portfolio, which currently consists of 15 marketed generic products and a pipeline of 37 products, and this acquisition will complement PuraCap’s own R D efforts by utilizing Epic’s strengths in the manufacture and development of controlled drug substances and …


Sanofi-Aventis U #pharma #company

Posted On Dec 19 2017 by

#drug manufacturer # Sanofi-Aventis U.S. LLC Latest Drug Information Updates Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent. Adlyxin Adlyxin (lixisenatide) is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist indicated. Xiidra Xiidra (lifitegrast) is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the. Epclusa Epclusa (sofosbuvir and velpatasvir) is a nucleotide analog polymerase inhibitor and pan-genotypic NS5A. Byvalson Byvalson (nebivolol and valsartan) is a beta adrenergic blocker and an angiotensin II receptor blocker (ARB). Zinbryta Zinbryta (daclizumab) is an interleukin-2 receptor blocking antibody indicated for the treatment of relapsing. More. Was this page helpful? …


Alliance Contract Pharma – Manufacturing and Lab Services #penn #pharma

Posted On Dec 19 2017 by

#contract pharmaceutical manufacturing # Welcome to Alliance Contract Pharma Alliance Contract Pharma is a leader in providing value-added services to our customers by creating a successful partnership with them throughout their project. Our pledge is to establish lasting relationships with our customers by exceeding their expectations and gaining their trust through exceptional performance. Alliance Contract Pharma has been privately owned since 2008 and has 70 years of combined experience in the pharmaceutical industry with an emphasis on contract manufacturing and laboratory services. We provide clinical and commercial product development, contract manufacturing, packaging and laboratory services for the pharmaceutical industry. Learn …


Specialty Pharmacy News – Drug Store News #pharmaceutical #contract #manufacturer

Posted On Dec 19 2017 by

#pharmacy news # Specialty Pharmacy News Two recent unanimous approval recommendations from FDA advisory committees regarding biosimilars is a signal of growing scientific acceptance and understanding of the biosimilar regulatory pathway, suggested The National Law Review in a report Tuesday. The National Law Review has created a chart summarizing pending and approved BLAs for biosimilars using publicly available information, the publication noted, but there are still two barriers to entry. As biosimilars gain FDA approval, patent issues remain a barrier and the exorbitant R D cost prevent significant price disparities. Accordingly, insurers may be slow to add biosimilars to the …


Community Pharmacy News (CPN): PSNC Main site #euro #pharma

Posted On Dec 19 2017 by

#pharmacy news # Community Pharmacy News (CPN) CPN, CPN, CPN, CPN, CPN, CPN, CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, CPN, CPN, CPN, CPN,CPN, CPN, …


Pharmaceutical Software #isis #pharma #products

Posted On Dec 19 2017 by

#pharma software # Pharmaceutical Software Pharmaceutical Software challenges are unique The pharmaceutical market is worth around US$980 billion per year, and continues to steadily rise. We understand these continuous changes and the regulations associated with the pharmaceutical industry, and have devised a system that will help you gain insight into your daily pharmaceutical operations without sacrificing a solid financial reporting foundation. Industry-standard functionality Pharmaceutical Software can handle all of the special manufacturing, distribution, and accounting needs of the pharmaceutical industry, including: Automatically prepare State control documents, such as the Pedigree Report required by some states that shows the full history …


MBA Programs in Pharmaceuticals: Beyond the Lab #core #pharma

Posted On Dec 19 2017 by

#pharma mba # MBA Programs in Pharmaceuticals: Beyond the Lab How MBA programs can help students tap into a wide range of roles in both big and small pharma firms By all accounts, the pharmaceutical industry is huge, and growing. Recent reports put the worldwide revenue from prescription drug sales as high as almost $1 trillion. And with developing middle classes needing more and more drugs in places like China and India, the industry is globalizing, and is not going to slow down anytime soon. Perhaps because of this growth potential, some business students are tuning in. A number of …


Top 100 Agencies 2014: Wunderman World Health – Medical Marketing and Media #valeant #pharma

Posted On Dec 19 2017 by

#pharma ad agencies # Top 100 Agencies 2014: Wunderman World Health Employing the tools clients and audiences want yields success Download: Wunderman World Health Well ahead of the curve is a place any business strives for. Wunderman World Health, which has been honing its expertise in the payer space, has been poised to steer clients through the healthcare moment payers, patients, physicians and pharmaceutical companies find themselves at now. “Our core value proposition is helping healthcare companies connect with that empowered consumer,” president Becky Chidester tells MM /* 728×90, создано 05.02.11 */ google_ad_slot = “6127977750”; google_ad_width = 670; google_ad_height = …


About OPIR #pharma #consulting #companies

Posted On Dec 19 2017 by

#pharmaceutical industry research # About OPIR Mission The Office of Pharmaceutical Industry Research (OPIR) was established in January 1999 by the Japan Pharmaceutical Manufacturers Association (JPMA). The OPIR has its mission to analyze the internal and external environments of the Japanese pharmaceutical industry and the mid-and-long-term issues it faces, and to make public policy recommendations based on its research. Objectives Through its research, the OPIR aims to develop an economic and social framework which contributes to the swift and continuous provision of innovative and efficacious medicines with appropriate prices. The framework should enhance access to and proper use of the …